Whitehawk Therapeutics Gross Margin Growth & History (WHWK)

Whitehawk Therapeutics's gross margin was 89.36% for fiscal 2025.

View full Whitehawk Therapeutics company overview

Whitehawk Therapeutics annual gross margin history

Whitehawk Therapeutics annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20252025-12-3189.36%+1.00 pp
20242024-12-3188.36%−0.10 pp
20232023-12-3188.47%−2.76 pp
20222022-12-3191.23%−8.77 pp
20212021-12-31100.00%

Whitehawk Therapeutics gross margin trends

Between the periods ended 2021-12-31 and 2025-12-31, Whitehawk Therapeutics's gross margin decreased from 100.00% to 89.36%, a change of −10.64 percentage points. The latest reported quarter, Q1 2025, shows 89.36%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Whitehawk Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about WHWK yet. Start the conversation.

Write the first post